Pharmafile Logo
Pharmafocus logo
Advanced Search

Bavarian Nordic courting cancer vaccine backers

November 12, 2010
Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

News

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010
Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …

News

Germany to cut drug prices by 2 billion euro

November 12, 2010
Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines

The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …

News
Avastin packs

NICE stands firm on Avastin rejection

November 12, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, colon cancer, metastatic colorectal cancer, patient access scheme

NICE has refused to recommend Roche’s blockbuster cancer drug Avastin for the treatment of metastatic colorectal cancer in its final …

News
amanda_callaghan

ABPI appoints communications director

November 11, 2010
Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing

UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …

Appointment
systemic lupus erythematosus

UCB lupus candidate shows disease benefits

November 11, 2010
Benlysta, Lupus, UCB, epratuzumab, monoclonal antibody, systemic lupus erythematosus

A new monoclonal antibody targeting the autoimmune disease lupus is continuing to show a positive effect on sufferers, its manufacturer …

News

Nycomed’s Q3 undermined by pantoprazole decline

November 11, 2010
Sales and Marketing Daxas, Guangdong Techpool Bio-Pharma, Nycomed, Protium, pantoprazole

Nycomed has seen its sales inch downwards in the third quarter, as the decline of its biggest seller pantoprazole continued. …

News

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010
Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …

News

Patients in UK cancer trials quadruples

November 11, 2010
Research and Development Cancer Research UK, NCRI, National Cancer Research Institute, UK clinical research, cancer trials

The number of cancer patients in the UK participating in clinical studies has quadrupled in the last decade, according to …

News

Novartis drops late stage lung cancer candidate

November 11, 2010
Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer

Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …

News

Digital for digital’s sake is out

November 10, 2010
Medical Communications digital creativity, digital marketing, ipad, seven stones, youtube

Creativity in the digital world is twofold. On the one hand there is technical wizardry and, on the other, there …

Feature

RSA expands global team

November 10, 2010
Business Services Matthew Edwards, Michelle Bosshard, Yildiz Biloglu, Zaki Sellam, appointment, business services, rsa

Life sciences executive search and interim management company RSA has made a number of appointments and internal promotions across its …

Appointment

Sanofi’s C diff vaccine fast tracked by FDA

November 10, 2010
Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur

A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …

News

Genzyme again snubs suitor Sanofi

November 10, 2010
Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …

News

Bayer rebrands pharma division

November 10, 2010
Medical Communications, Sales and Marketing Bayer Healthcare, Bayer cross, Byaer Schering Pharma, Marijn Dekkers, Xarelto, prix galien

The name Bayer Schering Pharma has been consigned to the corporate dustbin as its parent group institutes a branding shake-up. …

News

NICE limits access to cancer drugs, study confirms

November 10, 2010
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Cancer Drugs Fund, IPSOR, Maximilian Lebmeier, NICE, hta

NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …

News
Pfizer and Boehringer's COPD campaign website

Pfizer and Boehringer pilot COPD campaign

November 9, 2010
Medical Communications Boehringer Ingelheim, COPD, Pfizer, Salford, chronic bronchitis, chronic obstructive pulmonary disease, emphysema

Pfizer and Boehringer Ingelheim have mobilised a soap opera star, painted rugby players and a special ‘breathing bus’ for a …

News
Blog footer

Digital Pharma: Online health information reduces costs

November 9, 2010
Medical Communications Digital Pharma blog, Football Fan Fitness Challenge, NHS Choices, alcohol tracker iPhone app, online health information, patient information

The number of people using the official NHS website rose 10% in the last year, making it the most popular …

News

Improving Clinical Site Productivity

November 9, 2010
Sales and Marketing Kinapse, White paper

There are a number of factors in the industry that make clinical trials more costly, more time-consuming and requiring more …

News
Press release
Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010
Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026